Categories LATEST

Visa Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript

Some of the top companies are scheduled to report earnings today after markets close, and Visa Inc (NYSE: V) is one of them. The credit card giant’s stock traded slightly lower on Tuesday afternoon ahead of the third-quarter report.

Listen to Visa’s Q3 2023 earnings call live and read the real-time transcript

Wall Street is looking for an increase in Visa’s adjusted earnings to $2.12 per share in Q3 from $1.98 per share in the prior-year quarter. Revenue is expected to increase 10.8% year-over-year to $8.06 billion in the June quarter.

In the second quarter, all four operating segments expanded, driving up total revenues to $8.0 billion. Net income, on an adjusted basis, increased 17% annually to $2.09 per share. Unadjusted profit grew in double-digits to $4.3 billion or $2.03 per share.

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

Nike (NKE) looks set to beat hurdles and build a brighter future

Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business

Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company

Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor

Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top